The current method of harvesting bone marrow is...
1 hour+ in the operating room
Low cell yield can lead to even more time required
Cell yields and quality vary significantly
50-100+ punctures of anesthetized patient's pelvic bone
High variability in traditional marrow harvest reduces clinical outcomes and confounds clinical trials.
Donors experience significant pain due to multiple bone punctures
Recovery is slow
Onerous process discourages donation
THE REGENMED SOLUTION
RegenMed Systems has an exclusive technology license of IP from Stanford and has further developed the minimally invasive MarrowMiner, which in both preclinical and clinical trials has demonstrated its ability to safely and effectively collect more concentrated stem cells than traditional methods while patients are under only local anesthesia.
RegenMed harvest technology is poised to play a critical role in enabling a widening array of therapeutic approaches that utilize marrow derived cells, and can be paired with existing technologies for stem cell processing and site specific delivery.
Our minimally invasive Marrow Harvester powers regenerative medicine broadly. It is upstream and synergistic with cell separation and delivery technologies.